Author Archives: Julian Upton
Pharma to Flash the Cash to Counter Bleak Short-Term Outlook
Nearly two-thirds of US senior pharmaceutical executives surveyed by last month foresee a ‘full economic recovery’ by the end of 2013, with more than half of these pointing to an upturn in the industry’s fortunes by the end of next year.
However, 27 percent of the 100 executives interviewed by KPMG for its Industry Pulse Survey [...]
The Most Influential Pharma Leader Or Institution?
Ahead of Pharm Exec’s 30th Anniversary Issue later this year, we are assembling a list of pharma leaders who have made the most impact on the industry.
Which individual(s) or institution(s) do you think has had the most influence of the industry in the last 10–30 years?
Please leave a comment in the box below or drop [...]
The Most Influential Pharma Leader Or Institution?
Ahead of Pharm Exec’s 30th Anniversary Issue later this year, we are assembling a list of pharma leaders who have made the most impact on the industry.
Which individual(s) or institution(s) do you think has had the most influence of the industry in the last 10–30 years?
Please leave a comment in the box below or drop [...]
Warner-Chilcott's Cuts in Europe — Good News for US?
Any company announcing plans to ‘restructure’ and ‘repurpose’ itself tends to send out tremors across the industry, but for US employees of Dublin-headquartered Warner-Chilcott — the latest firm to use these tried and tested euphemisms — this could fuel a sigh of relief.

Roche Gets Tough on Greece